BMO Resumes Coverage On Tricon Residential After US IPO

Earlier this month, Tricon Residential (TSX: TCN) announced that they closed their U.S. IPO selling 46,248,746 shares for total proceeds of US$570 million, and completed their listing on the NYSE under the ticker “TCN”. Additionally, Tricon offered a private placement of shares to Blackstone Real Estate Investment Trust.

After the news, many analysts raised their 12-month price targets. The new 12-month price target sits at C$17.38. There are 8 analysts covering the stock with 2 having strong buy ratings and the other 6 have buys. The street high sits at C$19 from BMO Capital Markets while the lowest comes in at C$15.25.

BMO Capital Markets resumed their coverage with an outperform rating on Tricon Residential after the IPO and raised their 12-month price target to C$19 from C$18. They write, “We believe Tricon has a multi-year opportunity for FFO and BVPS growth while leveraging third-party fee-bearing equity capital and reducing leverage.”

BMO says that the net proceeds will be used to repay the amount outstanding under its pass-through certificates and the leftover money will be used to purchase future SFR JV-2 homes.

Below you can see BMO’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Raymond James Reiterates $6 Price Target On Organigram Holdings

On April 6th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they acquired cannabis 2.0...

Thursday, April 8, 2021, 10:37:00 AM

Bank Of America Upgrades Canopy Growth’s Price Target To C$36 From C$30

Last week, Canopy Growth (TSX: WEED) (NASDAQ: CGC) reported its fiscal second quarter 2021 financial...

Wednesday, November 18, 2020, 09:59:00 AM

Lyft Sees Several Analysts Raise Targets Following Q1 Earnings

Lyft Inc (NASDAQ: LYFT) opened up 2.5% higher Tuesday morning following the release of its...

Sunday, May 9, 2021, 12:24:00 PM

Endeavour Silver Beats BMO’s Production Estimates By 30%

Last week, Endeavour Silver Corp. (TSX: EDR) announced their third quarter production highlights. For the...

Thursday, October 14, 2021, 03:20:00 PM

Mindmed: Canaccord Calls Financing “Puzzling And Unusual”

This past week Mind Medicine Inc. (NEO: MMED) announced that they would be doing a...

Saturday, October 1, 2022, 01:04:00 PM